热门资讯> 正文

Grifols考虑部分美国生物制药业务IPO

2026-03-25 05:40

Spanish pharma Grifols, S.A. (GRFS) said that its board has decided to evaluate a potential US IPO of its shares of its US biopharma business.
The company said it was making the move as part of its "self-sufficiency program."
Grifols noted there is no guarantee an IPO will go through and would need to go through regulatory and legal requirements, internal approvals, and favorable market conditions.

More on Grifols, S.A.

Grifols: I'm Very Happy To Add In 2026
Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript
Grifols, S.A. 2025 Q4 - Results - Earnings Call Presentation
Historical earnings data for Grifols, S.A.
Dividend scorecard for Grifols, S.A.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。